Combination therapy of glucocorticoids and proteasome inhibitors
Many disorders of the CNS change the functionality and integrity of the BBB. Glucocorticoids (GC) are being used successfully in the treatment of some disorders while their effects on others are questionable and the nature of the underlying molecular mechanisms is still a matter of debate. While glucocorticoids potently stabilize the blood brain barrier in neoplastic and inflammatory central nervous system disorders, they are however ineffective in other diseases of the CNS affecting BBB integrity.
Excessive proteasomal glucocorticoid receptor degradation has been identified as an important mechanism causing pharmacological insensitivity of brain microvascular endothelial cells to glucocorticoids in ischemic brain disorders like acute ischemic stroke. In vitro and in vivo, restoration of glucocorticoid sensitivity and effective edema reduction was achieved by inhibition of the proteasomal pathway by Bortezomib accompanied by treatment with a specific glucocorticoid.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
